[HTML][HTML] Transcription factor Runx2 is a regulator of epithelial–mesenchymal transition and invasion in thyroid carcinomas

…, T Kondo, T Nakazawa, N Oishi, T Kawasaki… - Laboratory …, 2012 - nature.com
Runx2/Cbfa1 is a member of the Runt-related transcription factor family and is an essential
regulator of osteoblast/chondrocyte differentiation. Recently, aberrant expression of Runx2 …

Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells

…, T Nakazawa, DF Niu, K Mochizuki, T Kawasaki… - Human pathology, 2010 - Elsevier
Extracellular adenosine regulates a wide variety of physiological processes by interacting
with 4 adenosine receptor subtypes: A1, A2A, A2B, and A3. However, little is known of their …

[HTML][HTML] TIGIT/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment

…, Y Umeda, Y Nakamura, T Kawasaki… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Patients with cancer benefit from treatment with immune checkpoint inhibitors (ICIs),
and those with an inflamed tumor microenvironment (TME) and/or high tumor mutation …

[HTML][HTML] Epigenetic silencing of TTF-1/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas

…, D Ma, D Niu, K Mochizuki, T Kawasaki… - Laboratory …, 2009 - nature.com
Thyroid transcription factor-1 (TTF-1), also known as NKX2-1, is a homeodomain containing
transcriptional factor identified in thyroid, lung and central nervous system. In the thyroid, TTF…

Global histone modification of histone H3 in colorectal cancer and its precursor lesions

…, T Kondo, D Ma, D Niu, K Mochizuki, T Kawasaki… - Human pathology, 2012 - Elsevier
Chromatin remodeling through histone modification is an important mechanism of epigenetic
gene dysregulation in human cancers. However, little is known about global alteration of …

Expression of MHC Class I on breast cancer cells correlates inversely with HER2 expression

…, Y Kawaguchi, S Inoue, T Kawasaki… - …, 2012 - Taylor & Francis
HER2 is a promising target for immunotherapeutic interventions with T cell-based approaches
since it is amplified and overexpressed in 20–30% of breast cancers. However, several …

[HTML][HTML] EHF suppresses cancer progression by inhibiting ETS1-mediated ZEB expression

…, T Kawataki, K Miyake, H Ishii, T Kawasaki… - Oncogenesis, 2021 - nature.com
ETS homologous factor (EHF) belongs to the epithelium-specific subfamily of the E26
transformation-specific (ETS) transcription factor family. Currently, little is known about EHF’s …

Diagnostic performance of on-site computed CT-fractional flow reserve based on fluid structure interactions: comparison with invasive fractional flow reserve and …

S Fujimoto, T Kawasaki, KK Kumamaru… - European Heart …, 2019 - academic.oup.com
Aims We evaluated diagnostic accuracy of CT-fractional flow reserve (CT-FFR) computed on-site
with a new vendor workstation, against invasive FFR as the reference standard. …

Identification of integrin α3 as a molecular marker of cells undergoing epithelial–mesenchymal transition and of cancer cells with aggressive phenotypes

T Shirakihara, T Kawasaki, A Fukagawa… - Cancer …, 2013 - Wiley Online Library
Epithelial–mesenchymal transition ( EMT ) is a crucial event in wound healing, tissue repair,
and cancer progression in adult tissues. Transforming growth factor ( TGF )‐β induces EMT …

RET rearrangements and BRAF mutation in undifferentiated thyroid carcinomas having papillary carcinoma components

…, T Nakazawa, M Iwashina, T Kawasaki… - …, 2010 - Wiley Online Library
Mochizuki K, Kondo T, Nakazawa T, Iwashina M, Kawasaki T, Nakamura N, Yamane T, Murata
S‐i, Ito K, Kameyama K, Kobayashi M & Katoh R (2010) Histopathology 57, 444–450 RET …